Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease

There is an urgent need to identify biomarkers for Alzheimer’s disease (AD), but the identification of reliable blood-based biomarkers has proven to be much more difficult than initially expected. The current availability of high-throughput multi-omics data opens new possibilities in this titanic ta...

Full description

Bibliographic Details
Main Authors: Laura Madrid, Sandra C. Labrador, Antonio González-Pérez, María E. Sáez, The Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/12/2303